DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients | Zendy

Chiara Dalle Fratte | Zendy; Jerry Polesel | Zendy; Rossana Roncato | Zendy; De Mattia Elena | Zendy; Fabrizio Ecca | Zendy; Bignucolo Alessia | Zendy; Garziera Marica | Zendy; Dreussi Eva | Zendy; Palazzari Elisa | Zendy; Buonadonna Angela | Zendy; Guardascione Michela | Zendy; Berretta Massimiliano | Zendy; Luisa Foltran | Zendy; Sartor Franca | Zendy; D. Mario | Zendy; Adolfo Favaretto | Zendy; Mini Enrico | Zendy; Nobili Stefania | Zendy; De Paoli Antonino | Zendy; Toffoli Giuseppe | Zendy; Cecchin Erika | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients

Author(s) -

Chiara Dalle Fratte,

Jerry Polesel,

Rossana Roncato,

De Mattia Elena,

Fabrizio Ecca,

Bignucolo Alessia,

Garziera Marica,

Dreussi Eva,

Palazzari Elisa,

Buonadonna Angela,

Guardascione Michela,

Berretta Massimiliano,

Luisa Foltran,

Sartor Franca,

D. Mario,

Adolfo Favaretto,

Mini Enrico,

Nobili Stefania,

De Paoli Antonino,

Toffoli Giuseppe,

Cecchin Erika

Publication year - 2018

Publication title -

journal of molecular and clinical medicine

Language(s) - Uncategorized

Resource type - Journals

eISSN - 2617-5282

pISSN - 2616-3632

DOI - 10.31083/j.jmcm.2018.03.003

Subject(s) - dpyd , medicine , pharmacogenetics , colorectal cancer , oncology , single nucleotide polymorphism , snp , genotyping , allele , pharmacogenomics , population , pharmacology , genotype , cancer , genetics , biology , gene , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research